CXCL13 and myasthenia gravis: The latest research has found that the proportion of follicular helper T cells (Tfh) is increased in refractory MG patients, and serum CXCL13 levels are significantly elevated, suggesting that Tfh cell-mediated humoral immune abnormalities may be an important cause of the development and treatment resistance of this subtype (33).